Vivus, Inc. FDA Record
- Latest inspection NAI · Sep 8, 2023
- No warning letters matched by name
Vivus, Inc. has 1 FDA recall, 5 inspections, 2 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Vivus, Inc." is on file.
- Latest recall
- D-0896-2023 · Class III · Jun 23, 2023
- Latest inspection
- Sep 8, 2023 · NAI
- Latest 510(k)
- Dec 19, 2000
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 1 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 2 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 5 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Vivus, Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 1 | 0 | 0 | 1 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Vivus, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Vivus, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0896-2023 | Class III | PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured… | Jun 23, 2023 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Sep 8, 2023 | Campbell, CA | Drugs | No Action Indicated (NAI) | 3000719979 |
| Nov 28, 2018 | Campbell, CA | Drugs | No Action Indicated (NAI) | 3000719979 |
| Jan 31, 2014 | Campbell, CA | Drugs | No Action Indicated (NAI) | 3000719979 |
| Apr 26, 2013 | Campbell, CA | Drugs | Voluntary Action Indicated (VAI) | 3000719979 |
| Nov 30, 2011 | Campbell, CA | Drugs | No Action Indicated (NAI) | 3000719979 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3000719979 | Campbell, CA | 5 | Sep 8, 2023 |
Vivus, Inc. and the FDA: common questions
Has Vivus, Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "Vivus, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Vivus, Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Vivus, Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Vivus, Inc.?
The most recent FDA inspection on file ended Sep 8, 2023 at Campbell, CA and was classified NAI. FDA has 5 inspections of Vivus, Inc. on file.
Has Vivus, Inc. had an FDA recall?
Yes. Vivus, Inc. has 1 FDA recall on record. The most recent started Jun 23, 2023.
Need more than this page shows? Ask about Vivus, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.